Bette Caan to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Bette Caan has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
1.135
-
Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study. Drugs. 2009 Jul 30; 69(11):1445-57.
Score: 0.276
-
Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2218-25.
Score: 0.245
-
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008 Jun; 109(3):573-9.
Score: 0.240
-
Statin use and breast cancer: prospective results from the Women's Health Initiative. J Natl Cancer Inst. 2006 May 17; 98(10):700-7.
Score: 0.221
-
Statins as a free pass: Body mass index and other cardiovascular risk factors among lipid-lowering medication users and nonusers in the California Men's Health Study. Prev Med. 2019 12; 129:105822.
Score: 0.139
-
Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med. 2006 Feb 13; 166(3):357-65.
Score: 0.014